Compass Therapeutics (CMPX) Q2 2026 Earnings Report

591 Followers

CMPX Q2 2026 EPS Results

Actual EPS-$0.13

Consensus EPS-$0.11

Beat/MissMissed by -$0.02

One Year Ago EPS-$0.14

Actual Revenue$0.00

Expected Revenue-$600.00K

Beat/MissBeat by +$600.00K

YoY Revenue Growth―

QuarterQ2 2026

Date08/06/2026

TimeBefore Open

Conference CallThursday, August 6, 2026

CMPX Upcoming Earnings

Compass Therapeutics's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 11, 2026	2026 (Q3)	-0.13 / -	-0.08	―
Aug 06, 2026	2026 (Q2)	-0.11 / -0.13	-0.14	7.14% (+0.01)
May 05, 2026	2026 (Q1)	-0.10 / -0.10	-0.12	16.67% (+0.02)
Mar 05, 2026	2025 (Q4)	-0.09 / -0.09	-0.11	18.18% (+0.02)
Nov 05, 2025	2025 (Q3)	-0.14 / -0.08	-0.08	0.00% (0.00)
Aug 11, 2025	2025 (Q2)	-0.12 / -0.14	-0.1	-40.00% (-0.04)
May 08, 2025	2025 (Q1)	-0.11 / -0.12	-0.08	-50.00% (-0.04)
Feb 27, 2025	2024 (Q4)	-0.10 / -0.11	-0.11	0.00% (0.00)
Nov 12, 2024	2024 (Q3)	-0.11 / -0.08	-0.08	0.00% (0.00)
Jul 31, 2024	2024 (Q2)	-0.10 / -0.10	-0.09	-11.11% (-0.01)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed